Clinical Trial: Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate Cancer
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Prostatic Neoplasms, Castration-Resistant
Study Type: INTERVENTIONAL
Official Title: A Phase I, Open-Label, Dose-Finding Study of TVB-2640 Administered in Combination With Enzalutamide (Xtandi) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Brief Summary:
The purpose of this study is to determine what effects (good and bad) Enzalutamide and TVB-2640 have in the treatment of prostate cancer whose prostate cancer has spread to other parts of their body and that has not gotten better with previous treatment.This study is a Phase I clinical trial.Phase I clinical trials test the side effects of an investigational drug or an investigational combination with another drug."Investigational" means that the drug is still being studied and research doctors are…
Read more